OTLK icon

Outlook Therapeutics
OTLK

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$4
205% upside
High target

3 analyst ratings

positive
2  neutral
67%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
33% 1-yr OTLK win rate
30 Sep ‘25 18 days ago
Ascendiant Capital
Ascendiant Capital
Edward Woo
67% 1-yr OTLK win rate
22 Sep ‘25 26 days ago
Guggenheim
Guggenheim
Eddie Hickman
0% 1-yr OTLK win rate
29 Aug ‘25 1 month ago
Chardan Capital
Chardan Capital
Daniil Gataulin
28 Aug ‘25 1 month ago